{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:25:21Z","timestamp":1793139921654,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23767-5","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:33:28Z","timestamp":1763134408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The role of urine derived exosome metalloproteinases as biomarkers for prostate cancer detection may be confounded by non-malignant prostatic inflammation"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6224-894X","authenticated-orcid":false,"given":"Jad","family":"Najdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layal","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0938-5261","authenticated-orcid":false,"given":"Ola","family":"Hadadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6407-6501","authenticated-orcid":false,"given":"Talar","family":"Telvizian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7464-6408","authenticated-orcid":false,"given":"Christelle","family":"Dagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7312-4694","authenticated-orcid":false,"given":"Miza Salim","family":"Hammoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0043-7195","authenticated-orcid":false,"given":"Albert El","family":"Hajj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9719-9324","authenticated-orcid":false,"given":"Wassim","family":"Abou-Kheir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Mukherji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5084-7654","authenticated-orcid":false,"given":"Marwan","family":"El-Sabban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"3","key":"23767_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71 (3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"16","key":"23767_CR2","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJMms1914228","volume":"382","author":"HG Welch","year":"2020","unstructured":"Welch, H. G. & Albertsen, P. C. Reconsidering prostate cancer Mortality - The future of PSA screening. N Engl. J. Med. 382 (16), 1557\u20131563 (2020).","journal-title":"N Engl. J. Med."},{"issue":"4","key":"23767_CR3","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.eururo.2017.10.036","volume":"73","author":"V Cucchiara","year":"2018","unstructured":"Cucchiara, V. et al. Genomic markers in prostate cancer decision making. Eur. Urol. 73 (4), 572\u2013582 (2018).","journal-title":"Eur. Urol."},{"issue":"3","key":"23767_CR4","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1158\/0008-5472.CAN-08-3379","volume":"69","author":"H Song","year":"2009","unstructured":"Song, H., Li, Y., Lee, J., Schwartz, A. L. & Bu, G. Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9. Cancer Res. 69 (3), 879\u2013886 (2009).","journal-title":"Cancer Res."},{"issue":"1","key":"23767_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/jnci\/94.1.17","volume":"94","author":"JA Nemeth","year":"2002","unstructured":"Nemeth, J. A. et al. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis. J. Natl Cancer Inst. 94 (1), 17\u201325 (2002).","journal-title":"J. Natl Cancer Inst."},{"issue":"1","key":"23767_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1749-6632.1999.tb07690.x","volume":"878","author":"BL Lokeshwar","year":"1999","unstructured":"Lokeshwar, B. L. MMP Inhibition in prostate cancer. Ann. N. Y. Acad. Sci. 878 (1), 271\u2013289 (1999).","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"23","key":"23767_CR7","first-page":"8511","volume":"63","author":"D Trudel","year":"2003","unstructured":"Trudel, D., Fradet, Y., Meyer, F., Harel, F. & T\u00eatu, B. Significance of MMP-2 expression in prostate cancer: an immunohistochemical study. Cancer Res. 63 (23), 8511\u20138515 (2003).","journal-title":"Cancer Res."},{"issue":"2","key":"23767_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1023\/A:1006603723759","volume":"17","author":"T Itoh","year":"1999","unstructured":"Itoh, T. et al. Experimental metastasis is suppressed in MMP-9-deficient mice. Clin. Exp. Metastasis. 17 (2), 177\u2013181 (1999).","journal-title":"Clin. Exp. Metastasis"},{"key":"23767_CR9","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.2147\/IJN.S272378","volume":"15","author":"VC Kok","year":"2020","unstructured":"Kok, V. C. & Yu, C. C. Cancer-Derived exosomes: their role in cancer biology and biomarker development. Int. J. Nanomed. 15, 8019\u20138036 (2020).","journal-title":"Int. J. Nanomed."},{"issue":"9","key":"23767_CR10","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.trecan.2020.03.007","volume":"6","author":"VS LeBleu","year":"2020","unstructured":"LeBleu, V. S. & Kalluri, R. Exosomes as a multicomponent biomarker platform in cancer. Trends Cancer. 6 (9), 767\u2013774 (2020).","journal-title":"Trends Cancer"},{"issue":"11","key":"23767_CR11","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1111\/cas.12534","volume":"105","author":"TH Ung","year":"2014","unstructured":"Ung, T. H., Madsen, H. J., Hellwinkel, J. E., Lencioni, A. M. & Graner, M. W. Exosome proteomics reveals transcriptional regulator proteins with potential to mediate downstream pathways. Cancer Sci. 105 (11), 1384\u20131392 (2014).","journal-title":"Cancer Sci."},{"issue":"57","key":"23767_CR12","doi-asserted-by":"publisher","first-page":"97693","DOI":"10.18632\/oncotarget.18532","volume":"8","author":"J Pan","year":"2017","unstructured":"Pan, J., Ding, M., Xu, K., Yang, C. & Mao, L-J. Exosomes in diagnosis and therapy of prostate cancer. Oncotarget 8 (57), 97693 (2017).","journal-title":"Oncotarget"},{"issue":"20","key":"23767_CR13","doi-asserted-by":"publisher","first-page":"6610","DOI":"10.1158\/1078-0432.CCR-08-1136","volume":"14","author":"R Roy","year":"2008","unstructured":"Roy, R. et al. Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species. Clin. Cancer Res. 14 (20), 6610\u20136617 (2008).","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"23767_CR14","first-page":"324","volume":"69","author":"F Ma","year":"2017","unstructured":"Ma, F. et al. Matrix metalloproteinase 9 and prostate cancer risk: a meta-analysis of 1059 participants. Minerva Urol. Nefrol. 69 (4), 324\u2013329 (2017).","journal-title":"Minerva Urol. Nefrol"},{"issue":"1","key":"23767_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.21873\/anticanres.16169","volume":"43","author":"PH Li","year":"2023","unstructured":"Li, P. H. et al. Association of matrix Metalloproteinase-2 genotypes with prostate cancer risk. Anticancer Res. 43 (1), 343\u2013349 (2023).","journal-title":"Anticancer Res."},{"issue":"12","key":"23767_CR16","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.humpath.2010.05.001","volume":"41","author":"D Trudel","year":"2010","unstructured":"Trudel, D., Fradet, Y., Meyer, F. & T\u00eatu, B. Matrix metalloproteinase 9 is associated with Gleason score in prostate cancer but not with prognosis. Hum. Pathol. 41 (12), 1694\u20131701 (2010).","journal-title":"Hum. Pathol."},{"issue":"9","key":"23767_CR17","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/iju.13734","volume":"25","author":"K Fujita","year":"2018","unstructured":"Fujita, K. & Nonomura, N. Urinary biomarkers of prostate cancer. Int. J. Urol. 25 (9), 770\u2013779 (2018).","journal-title":"Int. J. Urol."},{"issue":"4","key":"23767_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/sj.pcan.4500750","volume":"7","author":"L Zhang","year":"2004","unstructured":"Zhang, L. et al. Type IV collagenase (matrix metalloproteinase-2 and-9) in prostate cancer. Prostate Cancer Prostatic Dis. 7 (4), 327\u2013332 (2004).","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"3\u20134","key":"23767_CR19","first-page":"230","volume":"75","author":"Z Han","year":"2008","unstructured":"Han, Z. et al. Zeng G-h. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer. Oncology 75 (3\u20134), 230\u2013236 (2008).","journal-title":"Oncology"},{"issue":"6","key":"23767_CR20","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00428-004-1016-2","volume":"444","author":"CG Sauer","year":"2004","unstructured":"Sauer, C. G. et al. Expression and activity of matrix metalloproteinases-2 and-9 in serum, core needle biopsies and tissue specimens of prostate cancer patients. Virchows Arch. 444 (6), 518\u2013526 (2004).","journal-title":"Virchows Arch."},{"key":"23767_CR21","doi-asserted-by":"crossref","unstructured":"SUN & X-b LIU C-d, WANG X-z. Expression and significance of MIP-1 alpha and MMP9 in the type \u2162 prostatitis. China J. Mod. Med. ;14. (2012).","DOI":"10.1155\/2012\/639735"},{"key":"23767_CR22","doi-asserted-by":"publisher","first-page":"112260","DOI":"10.1016\/j.ejmech.2020.112260","volume":"194","author":"S Mondal","year":"2020","unstructured":"Mondal, S., Adhikari, N., Banerjee, S., Amin, S. A. & Jha, T. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview. Eur. J. Med. Chem. 194, 112260 (2020).","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"23767_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1590\/S1677-55382012000200004","volume":"38","author":"ST Reis","year":"2012","unstructured":"Reis, S. T. et al. Underexpression of MMP-2 and its regulators, TIMP2, MT1-MMP and IL-8, is associated with prostate cancer. Int. Braz J. Urol. 38 (2), 167\u2013174 (2012).","journal-title":"Int. Braz J. Urol."},{"key":"23767_CR24","doi-asserted-by":"crossref","unstructured":"Rebbeck, T. R. (ed) Editor Prostate Cancer Genetics: Variation by race, ethnicity, and geography. Seminars in Radiation Oncology (Elsevier, 2017).","DOI":"10.1016\/j.semradonc.2016.08.002"},{"issue":"4","key":"23767_CR25","first-page":"651","volume":"62","author":"N Pouyanfar","year":"2016","unstructured":"Pouyanfar, N., Monabbati, A., Sharifi, A. A. & Dianatpour, M. Expression levels of MMP9 and PIWIL2 in prostate cancer: a Case-Control study. Clin. Lab. 62 (4), 651\u2013657 (2016).","journal-title":"Clin. Lab."},{"issue":"3","key":"23767_CR26","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3390\/cancers6031298","volume":"6","author":"Y Gong","year":"2014","unstructured":"Gong, Y., Chippada-Venkata, U. D. & Oh, W. K. Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression. Cancers (Basel). 6 (3), 1298\u20131327 (2014).","journal-title":"Cancers (Basel)"},{"issue":"1","key":"23767_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/(SICI)1098-2744(199601)15:1<57::AID-MC8>3.0.CO;2-P","volume":"15","author":"JD Knox","year":"1996","unstructured":"Knox, J. D. et al. Matrilysin expression in human prostate carcinoma. Mol. Carcinog. 15 (1), 57\u201363 (1996).","journal-title":"Mol. Carcinog."},{"key":"23767_CR28","doi-asserted-by":"publisher","first-page":"101747","DOI":"10.1016\/j.eclinm.2022.101747","volume":"55","author":"LNC Boyd","year":"2023","unstructured":"Boyd, L. N. C. et al. Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: A meta-analysis of aggregate and individual participant data. EClinicalMedicine 55, 101747 (2023).","journal-title":"EClinicalMedicine"},{"issue":"1","key":"23767_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12943-023-01741-x","volume":"22","author":"Y Lee","year":"2023","unstructured":"Lee, Y. et al. Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis. Mol. Cancer. 22 (1), 33 (2023).","journal-title":"Mol. Cancer"},{"issue":"2","key":"23767_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/bimj.201600226","volume":"60","author":"C Habermehl","year":"2018","unstructured":"Habermehl, C., Benner, A. & Kopp-Schneider, A. Addressing small sample size bias in multiple-biomarker trials: inclusion of biomarker-negative patients and Firth correction. Biom J. 60 (2), 275\u2013287 (2018).","journal-title":"Biom J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23767-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23767-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23767-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:33:31Z","timestamp":1763134411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23767-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23767"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23767-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The institutional review board at the American University of Beirut (IRB approval IM.DM.08, 19 August 2015) has approved the study and all patients and healthy subjects provided written informed consent. All methods were carried out in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and patient consent"}}],"article-number":"39929"}}